Spontaneous Bacterial Peritonitis (SBP) is a life-threatening infection that primarily affects patients with cirrhosis, particularly those with ascites. Ascites, the accumulation of fluid in the peritoneal cavity, is a common complication of liver disease, and SBP arises when bacteria from the bloodstream or intestines translocate into this fluid, triggering an infection without an obvious source. Recognizing and managing SBP is crucial for reducing morbidity and mortality in patients with cirrhosis .
Pathophysiology of SBP
SBP occurs due to bacterial translocation, a process where bacteria or bacterial products move from the intestinal lumen to the mesenteric lymph nodes and eventually into the bloodstream or ascitic fluid. This translocation is facilitated by several factors seen in cirrhosis, including increased intestinal permeability, impaired local immunity, and a hyperdynamic circulatory state that promotes bacterial migration .
The most common pathogens implicated in SBP are Gram-negative bacteria, particularly Escherichia coli and Klebsiella pneumoniae. Gram-positive organisms, such as Streptococcus species, are less common but still relevant . In rare cases, anaerobic bacteria may be responsible, but these are typically seen in more complex infections or in patients with secondary peritonitis.
Clinical Presentation
Patients with SBP may present with a variety of symptoms, making diagnosis challenging. Common clinical manifestations include:
Fever
Abdominal pain or tenderness
Worsening ascites
Altered mental status (encephalopathy)
Hypotension or shock in severe cases
It is important to note that up to 20% of patients with SBP may be asymptomatic, which makes regular screening in cirrhotic patients with ascites crucial .
Diagnosis of SBP
Diagnosis of SBP is based on the analysis of ascitic fluid obtained through paracentesis. The key diagnostic criterion is an ascitic fluid polymorphonuclear (PMN) leukocyte count of ≥250 cells/µL. This threshold is indicative of infection, even in the absence of a positive culture .
Although ascitic fluid cultures are important, they are often negative, particularly if patients have received antibiotics prior to paracentesis. A diagnostic paracentesis should be performed in all cirrhotic patients with ascites who develop any signs or symptoms suggestive of infection, or in those hospitalized for reasons unrelated to ascites, as SBP can often be subclinical .
Additional diagnostic measures include:
Ascitic fluid protein levels (typically low in SBP)
Lactate dehydrogenase (LDH) levels
Serum-ascitic fluid albumin gradient (SAAG) to rule out other causes of ascites
Blood cultures to identify bacteremia, which occurs in approximately 50% of SBP cases
Treatment and Management
Early recognition and treatment of SBP are critical for improving outcomes. Empiric antibiotic therapy should be initiated immediately upon suspicion of SBP, without waiting for culture results. The current standard treatment includes third-generation cephalosporins such as cefotaxime, which are effective against the common causative organisms .
In patients with a history of SBP or at high risk for recurrence, long-term prophylactic antibiotics such as norfloxacin or ciprofloxacin may be used to prevent future episodes. Prophylaxis is particularly indicated in patients with low ascitic fluid protein levels (<1.5 g/dL), advanced liver disease, or renal impairment .
Prognosis and Prevention
SBP is associated with a high mortality rate, particularly in patients with advanced liver disease. In-hospital mortality rates range from 20-40%, making early diagnosis and prompt treatment essential . Liver transplantation remains the only definitive treatment for patients with cirrhosis and recurrent SBP .
Preventive strategies focus on reducing bacterial translocation and strengthening the host's defenses. This includes the use of prophylactic antibiotics in high-risk patients and improving gut health through nutritional support .
Conclusion
Spontaneous Bacterial Peritonitis is a serious and often fatal complication of cirrhosis. Awareness, timely diagnosis, and appropriate management are the keys to reducing mortality in affected patients. Healthcare providers must maintain a high index of suspicion for SBP in any patient with cirrhosis and ascites, especially those presenting with new or worsening symptoms. Regular ascitic fluid analysis and early antibiotic intervention are essential in improving patient outcomes.
References
Garcia-Tsao, G., et al. (2012). "Spontaneous bacterial peritonitis in cirrhosis: diagnosis, treatment, and prevention." Hepatology, 56(2), 1138-1148.
Runyon, B. A. (2009). "Management of adult patients with ascites due to cirrhosis: an update." Hepatology, 49(6), 2087-2107.
Bauer, T. M., et al. (2002). "Bacterial translocation in cirrhotic rats." Gastroenterology, 122(4), 1004-1010.
Guarner, C., et al. (2006). "Pathogenesis of bacterial translocation in cirrhosis." Journal of Hepatology, 45(5), 102-110.
Evans, L. T., et al. (2003). "Spontaneous bacterial peritonitis in cirrhosis: A clinical perspective." The American Journal of Gastroenterology, 98(11), 2436-2441.
Rimola, A., et al. (2000). "Diagnosis, treatment, and prophylaxis of spontaneous bacterial peritonitis: a consensus document." Journal of Hepatology, 32(1), 142-153.
Tandon, P., & Garcia-Tsao, G. (2011). "Renal dysfunction is the most important independent prognostic factor in patients with cirrhosis." Gastroenterology, 140(7), 1762-1770.
Kamath, P. S., et al. (2001). "A model to predict survival in patients with end-stage liver disease." Hepatology, 33(2), 464-470.
Navasa, M., et al. (1996). "Bacteremia in spontaneous bacterial peritonitis: clinical and prognostic significance." Gastroenterology, 110(2), 484-490.
Wiest, R., et al. (2005). "Bacterial translocation in cirrhosis: the mechanism and clinical implications." Journal of Hepatology, 42(3), 224-232.
Fernández, J., et al. (2007). "Long-term efficacy of norfloxacin prophylaxis in patients with cirrhosis." Gastroenterology, 133(4), 1049-1056.
Ginés, P., & Rimola, A. (2001). "Renal dysfunction and infection in cirrhosis." Best Practice & Research Clinical Gastroenterology, 15(6), 819-834.
Borzio, M., et al. (1997). "Risk factors for the development of spontaneous bacterial peritonitis in patients with cirrhosis and ascites." Hepatology, 26(3), 758-763.
Poca, M., & Torres, M. (2011). "Management of spontaneous bacterial peritonitis in cirrhosis." Gastroenterology & Hepatology, 7(7), 464-471.
